MCLEAN, Va., Sept. 24, 2015 (GLOBE NEWSWIRE) -- Gladstone Commercial Corporation (NASDAQ:GOOD) (the "Company" or "Gladstone Commercial") announced today that it has executed a 7 year lease with Cardiac Cath Lab of Baytown, LP ("CCL") for 6,791 square feet at the Company's 12,000 square foot Baytown, TX medical office property. The property is adjacent to the San Jacinto Methodist Hospital and the lease is scheduled to commence January 1, 2016. CCL is a joint venture between seven doctors and National Cardiovascular Partners and will use the space to operate an outpatient cardiac catheterization and vascular lab.
"We are excited that CCL has chosen our property to launch this new joint venture. The recent increase in prospect activity for this well-located property is encouraging as we proceed toward full occupancy," said Buzz Cooper, Senior Managing Director of Gladstone Commercial.
The Tarantino Properties team of Peggy Rougeou represented Gladstone Commercial and the CBRE team of Chris Sido represented CCL in this transaction.
About Gladstone Commercial Corporation (NASDAQ:GOOD)
Gladstone Commercial is a real estate investment trust focused on acquiring, owning and operating net leased industrial and office properties across the United States. Gladstone Commercial's real estate portfolio consists of 101 properties located in 24 states, totaling approximately 11.1 million square feet. For additional information please visit www.gladstonecommercial.com.
All statements contained in this press release, other than historical facts, may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements. Readers should not rely upon forward-looking statements because the matters they describe are subject to known and unknown risks and uncertainties that could cause the Company's business, financial condition, liquidity, results of operations, funds from operations or prospects to differ materially from those expressed in or implied by such statements. Such risks and uncertainties are disclosed under the caption "Risk Factors" of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2014, as filed with the SEC on February 18, 2015 and the Company's Form 10-Q for the quarter ended June 30, 2015, as filed with the SEC on August 3, 2015. The Company cautions readers not to place undue reliance on any such forward-looking statements which speak only as of the date made. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
For Investor Relations inquiries related to any of the monthly dividend paying Gladstone funds, please visit www.gladstone.com.